Condition: Hepatic Impairment · Sponsor: Guangdong Raynovent Biotech Co., Ltd
The purpose of this study is to assess how fast RAY1225 gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants.
This description comes directly from the study's public registry record.
Zhongyuan XU · 020-62786845 · nfyygcp@126.com
Always discuss trial participation with your own doctor first.
| Nanfang Hospital,South Medical Hospital | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06577415